Log In
Sign Up
Find a Lawyer
Ask a Lawyer
Research the Law
Law Schools
Laws & Regs
Newsletters
Marketing Solutions
Justia Connect
Pro Membership
Practice Membership
Public Membership
Justia Lawyer Directory
Platinum Placements
Gold Placements
Justia Elevate
SEO
Websites
Blogs
Justia Amplify
PPC Management
Google Business Profile
Social Media
Justia Onward Blog
Justia
Patents
Patents Assigned to Redefine Nutrition, LLC
Patents Assigned to Redefine Nutrition, LLC
INCREASING BIOAVAILABILITY OF N-COUMAROYLDOPAMINE THROUGH CO-ADMINISTRATION WITH A CATECHOL-O-MEHTYLTRANSFERASE (COMT) INHIBITOR
Publication number:
20140107050
Abstract:
The present invention is directed to a composition including N-Coumaroyldopamine and a catechol-o-methyltransferase (COMT) inhibitor for promoting weight loss in a user.
Type:
Application
Filed:
October 14, 2013
Publication date:
April 17, 2014
Applicant:
Redefine Nutrition, LLC
Inventors:
Kyung S. Kim, Bryan J. Krause